In ovarian cancer, exosomal transfer of miR-433 can promote paclitaxel resistance through the induction of cell senescence related genes including cyclin-dependent kinase 6 (CDK6), MAPK14, E2F3, and CDKN2A. The gene discussed is CDK6; the disease is ovarian carcinoma.